摘要
本研究依据新型冠状病毒肺炎的发病季节和特点,认为本病与温病有本质的区别,属于伤寒的范畴;根据国家卫生健康委员会和国家中医药管理局发布的关于本病的诊疗方案中各试行版本描述的临床典型类型和非典型新型冠状病毒肺炎,运用六经辨证进行了分析和方药推荐。为非典、MERS、流感、禽流感、新型冠状病毒肺炎等严重影响人类健康的传染性疾病提供治疗参考。
According to the onset season and characteristics of COVID-19,believe that the disease is essentially different from Wenbing and belongs to Shanghan.According to the typical clinical types and atypical COVID-19 described in the trial versions of national health commission of the People’s Republic of China and national administration of traditional Chinese medicine,Liujing Bianzheng used for analysis and prescription recommendation.It provides reference for SARS,MERS,influenza,avian influenza,COVID-19 and other infectious diseases which seriously affect human health.
作者
王立石
石鹏
黄黎明
WANG Lishi;SHI Peng;HUANG Liming(Japan China Communication Meeting for Traditional Medicine,Japan Ageo 3620047)
出处
《陕西中医》
CAS
2021年第6期767-769,共3页
Shaanxi Journal of Traditional Chinese Medicine